Outcomes of suction curettage and mifepristone abortion in the United States
Tài liệu tham khảo
Legarth, 1991, Mifepristone or vacuum aspiration in termination of early pregnancy, Eur J Obstet Gynecol Repro Bio, 41, 91, 10.1016/0028-2243(91)90085-Y
Chan, 1993, Blood loss in termination of early pregnancy by vacuum aspiration and by combination of mifepristone and gemeprost, Contraception, 47, 85, 10.1016/0010-7824(93)90111-J
Thong, 1992, What do women want during medical abortion?, Contraception, 46, 435, 10.1016/0010-7824(92)90147-L
Holmgren, 1992, Women’s evaluation of three early abortion methods, Acta Obstet Gynecol Scand, 71, 616, 10.3109/00016349209006230
Urquhart, 1991, Psychiatric morbidity and acceptability following medical and surgical methods of induced abortion, Br J Obstet Gynecol, 98, 396, 10.1111/j.1471-0528.1991.tb13431.x
Bachelot, 1992, Conditions for choosing between drug induced and surgical abortion, Contraception, 45, 547, 10.1016/0010-7824(92)90106-4
Winikoff, 1997, Safety, efficacy, and acceptability of medical abortion in China, Cuba, and India, Am J Obstet Gynecol, 176, 431, 10.1016/S0002-9378(97)70511-8
Spitz, 1998, Early pregnancy termination with mifepristone and misoprostol in the United States, N Engl J Med, 338, 1241, 10.1056/NEJM199804303381801
Peyron, 1993, Early termination of pregnancy with mifepristone (RU486) and the orally active prostaglandin misoprostol, N Engl J Med, 328, 1509, 10.1056/NEJM199305273282101
Silvestre, 1990, Voluntary interruption of pregnancy with mifepristone (RU 486) and a prostaglandin analogue, N Engl J Med, 322, 645, 10.1056/NEJM199003083221001
Ullmann, 1992, Medical termination of early pregnancy with mifepristone (RU 486) followed by a prostaglandin analogue. Study in 16,369 women, Acta Obstet Gynecol Scand, 71, 278, 10.3109/00016349209021052
Norman, 1992, Medical abortion in women of less than or equal to 56 days amenorrhoea, Br J Obstet Gynecol, 99, 601, 10.1111/j.1471-0528.1992.tb13830.x
Urquhart, 1997, The efficacy and tolerance of mifepristone and prostaglandin in termination of pregnancy of less than 63 days gestation; UK Multicentre Study—final results, Contraception, 55, 1, 10.1016/S0010-7824(96)00252-1
Beckman, 1997, Experience and acceptability of medical abortion with mifepristone and misoprostol among U.S. women, Women Health Issues, 7, 253, 10.1016/S1049-3867(97)00117-5
el-Refaey, 1995, Induction of abortion with mifepristone (RU 486) and oral or vaginal misoprostol, N Engl J Med, 332, 983, 10.1056/NEJM199504133321502
Creinin, 1997, Contraception, 56, 367, 10.1016/S0010-7824(97)00173-X
Creinin, 1997, Medical abortion with oral methotrexate and vaginal misoprostol, Obstet Gynecol, 90, 611, 10.1016/S0029-7844(97)00266-4
Wiebe, 1997, Abortion induced with methotrexate and misoprostol, Contraception, 55, 159, 10.1016/S0010-7824(97)00021-8
Grimes, 1997, Medical abortion in early pregnancy, Obstet Gynecol, 89, 790, 10.1016/S0029-7844(97)81439-1